GOLD Sponsor
Visit the Aspen Pharmacare website
SILVER Sponsor
International Speaker Sponsor
Janet Antrobus, the daughter of Philip and Barbara Sceales was diagnosed with breast cancer at 30 years. The lump was picked up on a pregnancy examination, and after surgery, she faced the emotional trauma of both a complete mastectomy as well as the removal of her baby. Then, re-construction was not on offer.
Those early years of breast cancer treatment were somewhat barbaric by today’s understanding and empathy. There was only one unit where chemotherapy was administered, entailing an hour’s drive in both directions for treatment, with violent aftermath results of continuous vomiting on the journey home, and thereafter. The all-male medical offering of the time was not particularly conducive to kindness and sympathy, making the treatment process an ongoing ordeal.
Janet’s treatment enabled a long duration of survival but at enormous emotional and mental cost. Her cancer metastasised initially to the bones, and later to the lungs. Her children were young when she was initially diagnosed, and the effect of their sick and anxious mother played havoc in their own youthful development and their young adult life.
The Trust was set up in discussion with Janet: she was desperately anxious no one would remember her, her children would forget her and all the other fears facing a young woman as death approached. The irony lies in how often we do talk and remember her, and the satisfaction of knowing how the Trust has helped in a small way to contribute towards the superb treatment now available for many.
Over the past three decades, it has been a privilege to watch the extraordinary dedication and generosity of visiting cancer specialists from all over the world, sharing their knowledge, enabling the transformation of breast cancer treatment into a journey of loving care, kindness and consideration towards both the patient and attendant family.
As a family, we are hugely indebted to the many leading medical specialists who have agreed to visit South Africa, whilst sharing their expertise with their local colleagues.
Janet Antrobus, the daughter of Philip and Barbara Sceales was diagnosed with breast cancer at 30 years. The lump was picked up on a pregnancy examination, and after surgery, she faced the emotional trauma of both a complete mastectomy as well as the removal of her baby. Then, re-construction was not on offer.
Those early years of breast cancer treatment were somewhat barbaric by today’s understanding and empathy. There was only one unit where chemotherapy was administered, entailing an hour’s drive in both directions for treatment, with violent aftermath results of continuous vomiting on the journey home, and thereafter. The all-male medical offering of the time was not particularly conducive to kindness and sympathy, making the treatment process an ongoing ordeal.
Janet’s treatment enabled a long duration of survival but at enormous emotional and mental cost. Her cancer metastasised initially to the bones, and later to the lungs. Her children were young when she was initially diagnosed, and the effect of their sick and anxious mother played havoc in their own youthful development and their young adult life.
The Trust was set up in discussion with Janet: she was desperately anxious no one would remember her, her children would forget her and all the other fears facing a young woman as death approached. The irony lies in how often we do talk and remember her, and the satisfaction of knowing how the Trust has helped in a small way to contribute towards the superb treatment now available for many.
Over the past three decades, it has been a privilege to watch the extraordinary dedication and generosity of visiting cancer specialists from all over the world, sharing their knowledge, enabling the transformation of breast cancer treatment into a journey of loving care, kindness and consideration towards both the patient and attendant family.
As a family, we are hugely indebted to the many leading medical specialists who have agreed to visit South Africa, whilst sharing their expertise with their local colleagues.
Breakfast Symposium Sponsor
Post Lunch Symposium Sponsor
Mini Seminar
Visit the Aspen Pharmacare website
Visit the Busamed Oncology website
Local Speakers Sponsors
CPD Sponsor
Best Presentation Award Sponsor
Exhibitors
Friend of BIGOSA
Exhibitor – Stand 29
Through our industry position as a global pharmaceutical company, with a relevant portfolio of medicines and strategic manufacturing capability, we contribute to furthering the World Health Organization’s (“WHO’s”) goal of Universal Health Care Coverage and advancing the outcomes of the United Nations SDG3 of “ensuring healthy lives and promoting well-being for all at all ages”. Aligned to our ethos Healthcare. We Care. we strive to improve health and quality of life of patients while building trust, creating shared value and making a positive impact as a responsible corporate citizen.
Exhibitor – Stand 17
We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, the planet and our shareholders.
Our Purpose underpins everything we do. It gives us a reason to come to work every day. It reminds us why we exist as a company. It helps us deliver benefits to patients and create value for shareholders.
Our Values determine how we work together and the behaviours that drive our success. They guide our decision making and define our beliefs.
Exhibitor – Stand 15
BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare.